A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)

Clinical trial NCT01340937 · COMPLETED

Trial details

NCT number: NCT01340937
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bacterial Infections Virus Diseases

Start date: 2011-05-10
Primary completion: 2012-12-18
Enrollment: 2808

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.